Ebtehal El‐Demerdash
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 5%
- Liver physiology and pathology
Papers in
- Hepatology 13
- Liver physiology and pathology 9
-
- Drug-Induced Hepatotoxicity and Protection 8
- Co-authors
- Wesam M. El‐Bakly (9 shared papers)Eman M. Mantawy (11 shared papers)Ahmed Esmat (8 shared papers)Hala Osman EL-Mesallamy (8 shared papers)Sara A. Wahdan (14 shared papers)Riham Soliman Said (7 shared papers)Ashraf B. Abdel‐Naim (12 shared papers)Doaa A. Elsherbiny (9 shared papers)
- Journals
- Toxicology and Applied Pharmacology (7 papers)European Journal of Pharmacology (5 papers)Life Sciences (5 papers)Journal of Pharmacy and Pharmacology (4 papers)Scientific Reports (4 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Ebtehal El‐Demerdash
84 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 115
- Pharmacology 244
- Hepatology 155
- Geriatrics and Gerontology 62
- Complementary and alternative medicine 144
- Biochemistry 101
Countries citing papers authored by Ebtehal El‐Demerdash
This map shows the geographic impact of Ebtehal El‐Demerdash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebtehal El‐Demerdash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebtehal El‐Demerdash more than expected).
Fields of papers citing papers by Ebtehal El‐Demerdash
This network shows the impact of papers produced by Ebtehal El‐Demerdash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebtehal El‐Demerdash. The network helps show where Ebtehal El‐Demerdash may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebtehal El‐Demerdash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 228 | |
| 2 | 2010 | 119 | |
| 3 | 2016 | 106 | |
| 4 | 2012 | 100 | |
| 5 | 2017 | 99 | |
| 6 | 2013 | 84 | |
| 7 | 2014 | 80 | |
| 8 | 2011 | 79 | |
| 9 | 2021 | 78 | |
| 10 | 2012 | 73 | |
| 11 | 2016 | 65 | |
| 12 | 2021 | 61 | |
| 13 | 2021 | 61 | |
| 14 | 2013 | 60 | |
| 15 | 2010 | 55 | |
| 16 | 2021 | 45 | |
| 17 | 2012 | 45 | |
| 18 | 2011 | 43 | |
| 19 | 2020 | 43 | |
| 20 | 2013 | 40 |
About Ebtehal El‐Demerdash
Ebtehal El‐Demerdash is a scholar working on Hepatology, Pharmacology, Epidemiology, Biological Psychiatry and Reproductive Medicine, having authored 85 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Liver physiology and pathology (9 papers), Cancer-related cognitive impairment studies (8 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Reproductive Biology and Fertility (7 papers), Tryptophan and brain disorders (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). The work is most often cited by research in Pharmacology (244 citations), Hepatology (155 citations), Geriatrics and Gerontology (62 citations), Complementary and alternative medicine (144 citations) and Biochemistry (101 citations). Ebtehal El‐Demerdash has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Wesam M. El‐Bakly, Eman M. Mantawy, Ahmed Esmat, Hala Osman EL-Mesallamy, Sara A. Wahdan, Riham Soliman Said, Ashraf B. Abdel‐Naim, Doaa A. Elsherbiny, Amira Mohamed Badr and Samar H. Gerges. Their work appears in journals such as Toxicology and Applied Pharmacology, European Journal of Pharmacology, Life Sciences, Journal of Pharmacy and Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.